检索结果 - Konstanze Döhner
- Showing 1 - 20 results of 150
- Go to Next Page
-
1
Molecular characterization of acute myeloid leukemia 由 Konstanze Döhner, H. Döhner
出版 2008Editorial -
2
-
3
-
4
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B 由 Stefan Fröhling, Richard F. Schlenk, Sabine Käyser, Martina Morhardt, Axel Benner, Konstanze Döhner, Hartmut Döhner
出版 2006Artigo -
5
Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut) 由 Jochen Greiner, Vanessa Schneider, Michael Schmitt, Marlies Götz, Konstanze Döhner, Markus Wiesneth, Hartmut Döhner, Susanne Hofmann
出版 2013Carta -
6
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms 由 Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm
出版 2013Artigo -
7
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm 由 Stefan Fröhling, Richard F. Schlenk, Jochen Breitruck, Axel Benner, Sylvia Kreitmeier, Karen Tobis, Hartmut Döhner, Konstanze Döhner
出版 2002Artigo -
8
-
9
-
10
-
11
-
12
-
13
<i>CEBPA</i> Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations 由 Stefan Fröhling, Richard F. Schlenk, Ina Stolze, Jörg Bihlmayr, Axel Benner, Sylvia Kreitmeier, Karen Tobis, Hartmut Döhner, Konstanze Döhner
出版 2004Artigo -
14
-
15
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (V... 由 Olga Grishina, Claudia Schmoor, Konstanze Döhner, Björn Hackanson, Beate Lubrich, Annette M. May, Caroline Cieslik, Michael J. Müller, Michael Lübbert
出版 2015Artigo -
16
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations 由 Konstanze Döhner, Richard F. Schlenk, Marianne Habdank, Claudia Scholl, Frank G. Rücker, Andrea Corbacioglu, Lars Bullinger, Stefan Fröhling, Hartmut Döhner
出版 2005Artigo -
17
Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of <i>Mycobacterium tuberculosis</i> in Human Macrophages 由 Heiko Bruns, Frank Stegelmann, Mario Fabri, Konstanze Döhner, Ger van Zandbergen, Manfred Wagner, Mhairi Skinner, Robert L. Modlin, Steffen Stenger
出版 2012Artigo -
18
-
19
-
20
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX ge... 由 Ying Qu, Andreas Lennartsson, Verena I. Gaidzik, Stefan Deneberg, Mohsen Karimi, Sofia Bengtzén, Martin Höglund, Lars Bullinger, Konstanze Döhner, Sören Lehmann
出版 2014Artigo
相关主题
Biology
Gene
Medicine
Myeloid leukemia
Genetics
Internal medicine
Cancer research
Oncology
Leukemia
Myeloid
Mutation
Chromosome
Karyotype
Immunology
NPM1
Gene expression
Biochemistry
Stem cell
Gastroenterology
Transplantation
Bone marrow
Chemotherapy
Haematopoiesis
Transcription factor
Cell biology
Confidence interval
Cytarabine
Hazard ratio
CEBPA
Cancer